Pioche-Durieu and colleagues have demonstrated that Epstein–Barr virus (EBV)-infected nasopharyngeal carcinoma (NPC) cells express abundant amounts of galectin 9 (64), a molecule shown to be an agonist of Tim-3 (65). The gene discussed is LGALS9; the disease is nasopharyngeal carcinoma.